Skip to main navigation
AthenexAthenex
Athenex
Improving the lives of cancer patients everywhere
  • About
    • About Athenex
    • Our Team
      • Board of Directors
      • Leadership
      • Other Key Employees
      • Advisors
    • Partnerships
    • Contact
  • Oncology Innovation
    • Pipeline
    • Technology Platform
      • Orascovery
      • Src Kinase Inhibition
      • Arginine Deprivation Therapy
      • TCR-T Immunotherapy
      • Dual Inhibition
    • Clinical Trials
  • Operating Platforms
    • Commercial
    • Internal Supply Chain
  • Investor Relations
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Events & Presentations
    • Financial Information
      • SEC Filings
      • Annual Meeting Materials
      • Annual Reports
      • Quarterly Results
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Information Request
      • E-mail Alerts
      • IR Contacts
  • Careers
Menu back  

SEC Filings

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Nov 12, 2019
Document Date
Sep 30, 2019
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Athenex, Inc.
Issuer
Athenex, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

sidebar nav

  • Overview
  • Stock Information
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • News & Events
    • Press Releases
    • Events & Presentations
  • Financial Information
    • SEC Filings
    • Annual Meeting Materials
    • Annual Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts
  • Print Page Print Page
  • RSS RSS
  • E-mail Alerts E-mail Alerts
Athenex - Improving the lives of cancer patients everywhere
QUICK LINKS

About Athenex
Our Team
Partnerships
Contact

QUICK LINKS

Pipeline
Orascovery
Src Kinase Inhibition
Arginine Deprivation Therapy
TCR-T Immunotherapy
Clinical Trials

QUICK LINKS

Commercial
Internal Supply Chain

QUICK LINKS

News
Investor Relations
Careers

OTHER ATHENEX SITES

Athenex Oncology

Commercializing our proprietary products

Athenex Pharmaceutical Division
Athenex Pharma Solutions

Specialty pharmaceuticals and 503B business

Polymed

cGMP API manufacturing and distribution

© 2019 Athenex, Inc. All rights reserved.

  • Privacy Policy
  • Terms of Use